-
18 July – 22 July 2016
1st Day
Day One
The University of Hong Kong
09:10 – 10:40
Immunologic principles of vaccination
14:00 – 15:30
Evaluating serological responses induced by influenza vaccination
16:00 – 17:30
Planning a phase III vaccine trial: How big does it have to be?
2nd Day
Day Two
The University of Hong Kong
09:00 – 10:30
Disease surveillance: Clinical, virological, serological and internet-based surveillance
11:00 – 12:30
Updating vaccines based on molecular epidemiology studies: genetic and antigenic surveillance
14:00 – 15:30
Inferring disease burden from surveillance data
16:00 – 17:30
Selecting a vaccine strain for influenza virus?
3rd Day
Day Three
The University of Hong Kong
09:00 – 10:30
Infectious disease modeling
11:00 – 12:30
Health economic evaluation of vaccination programs
14:00 – 15:30
Optimizing vaccination strategies: Targeting high-transmitters or high-risk groups?
16:00 – 17:30
The benefit is worth the risk: The case of rotavirus vaccine
4th Day
Day Four
The University of Hong Kong
11:00 – 12:30
Communicating the risks and benefits of vaccines to the public
14:00 – 16:00
Panel discussion: Lessons from the 2009 influenza pandemic
Pauline Paterson
Thomas Abraham
Gabriel Leung
Hongjie Yu
5th Day
Day Five
The University of Hong Kong
09:00 – 10:30
Post-marketing safety and efficacy surveillance
11:00 – 12:30
Vaccine licensure in China